Sio Capital Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Sio Capital Management, LLC
- $209 Million
- Q2 2025
A detailed history of Sio Capital Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 507,700 shares of APLS stock, worth $12.1 Million. This represents 11.02% of its overall portfolio holdings.
Number of Shares
507,700Holding current value
$12.1 Million% of portfolio
11.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
295Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$291 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$283 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$242 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$232 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$214 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.61B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...